{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T22:10:13Z","timestamp":1775167813697,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T00:00:00Z","timestamp":1515024000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12253-017-0379-z","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T05:42:31Z","timestamp":1515044551000},"page":"141-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study"],"prefix":"10.1007","volume":"26","author":[{"given":"Rabeb M.","family":"Ghali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam A.","family":"Al-Mutawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bashayer H.","family":"Ebrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanen H.","family":"Jrah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Zaied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanen","family":"Bhiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahmi","family":"Hmila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Touhami","family":"Mahjoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wassim Y.","family":"Almawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,4]]},"reference":[{"key":"379_CR1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s10552-014-0491-2","volume":"10","author":"L Fan","year":"2015","unstructured":"Fan L, Goss PE, Strasser-Weippl K (2015) Current status and future projections of breast cancer in Asia. Breast Care (Basel) 10:372\u2013378. \nhttps:\/\/doi.org\/10.1007\/s10552-014-0491-2","journal-title":"Breast Care (Basel)"},{"key":"379_CR2","doi-asserted-by":"publisher","first-page":"915610","DOI":"10.1155\/2012\/915610","volume":"2012","author":"GO Abdulrahman Jr","year":"2012","unstructured":"Abdulrahman GO Jr, Rahman GA (2012) Epidemiology of breast cancer in Europe and Africa. J Cancer Epidemiol 2012:915610. \nhttps:\/\/doi.org\/10.1155\/2012\/915610","journal-title":"J Cancer Epidemiol"},{"key":"379_CR3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.5114\/aoms.2012.30289","volume":"8","author":"H Mojgan","year":"2012","unstructured":"Mojgan H, Massoud H, Ahmad E (2012) ERCC1 intron 1 was associated with breast cancer risk. Arch Med Sci 8:655\u2013658. \nhttps:\/\/doi.org\/10.5114\/aoms.2012.30289","journal-title":"Arch Med Sci"},{"key":"379_CR4","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.5114\/aoms.2014.47830","volume":"10","author":"MP Gallegos","year":"2014","unstructured":"Gallegos MP, Figuera LE, Ramos MC, Salas E, Puebla AM, Peralta V, Gaecia JE, Davalos IP, Z\u00fa\u00f1iga GM (2014) The association between the 844ins68 polymorphism in the CBS gene and breast cancer. Arch Med Sci 10:1214\u20131224. \nhttps:\/\/doi.org\/10.5114\/aoms.2014.47830","journal-title":"Arch Med Sci"},{"key":"379_CR5","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.4238\/2013","volume":"12","author":"L G\u00f3mez Flores-Ramos","year":"2013","unstructured":"G\u00f3mez Flores-Ramos L, Escoto-De Dios A, Puebla-P\u00e9rez AM, Figuera-Villanueva LE, Ramos-Silva A, Ram\u00edrez-Pati\u00f1o R, Delgado-Saucedo JI, Salas-Gonz\u00e1lez E et al (2013) Association of the tumor necrosis factor-alpha \u2013308G>A polymorphism with breast cancer in Mexican women. Genet Mol Res 12:5680\u20135693. \nhttps:\/\/doi.org\/10.4238\/2013","journal-title":"Genet Mol Res"},{"key":"379_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.5114\/aoms.2012.28558","volume":"8","author":"YL Xu","year":"2012","unstructured":"Xu YL, Sun Q, Shan GL, Zhang J, Liao HB, Li SY, Jiang J, Shao ZM et al (2012) A case-control study on risk factors of breast cancer in China. Arch Med Sci 8:303\u2013309. \nhttps:\/\/doi.org\/10.5114\/aoms.2012.28558","journal-title":"Arch Med Sci"},{"key":"379_CR7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT et al (2000) Molecular portraits of human breast tumours. Nature 406:747\u2013752","journal-title":"Nature"},{"key":"379_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10552-014-0491-2","volume":"26","author":"SJ Nyante","year":"2015","unstructured":"Nyante SJ, Gammon MD, Kaufman JS, Bensen JT, Lin DY, Barnholtz-Sloan JS, Hu Y, He Q, Luo J, Millikan RC (2015) Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects. Cancer Causes Control 26:121\u2013131. \nhttps:\/\/doi.org\/10.1007\/s10552-014-0491-2","journal-title":"Cancer Causes Control"},{"key":"379_CR9","doi-asserted-by":"publisher","first-page":"e992222","DOI":"10.4161\/2162402X.2014.992222","volume":"4","author":"N Eir\u00f3","year":"2015","unstructured":"Eir\u00f3 N, Fernandez-Garcia B, V\u00e1zquez J, Del Casar JM, Gonz\u00e1lez LO, Vizoso FJ (2015) A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer. Oncoimmunology 4:e992222","journal-title":"Oncoimmunology"},{"key":"379_CR10","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/bjs.1800741118","volume":"74","author":"RA Hawkins","year":"1987","unstructured":"Hawkins RA, White G, Bundred NJ, Dixon JM, Miller WR, Stewart HJ, Forrest AP (1987) Prognostic significance of oestrogen and progestogen receptor activities in breast cancer. Br J Surg 74:1009\u20131013","journal-title":"Br J Surg"},{"key":"379_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/0020-711X(90)90033-Y","volume":"22","author":"JF Savouret","year":"1990","unstructured":"Savouret JF, Misrahi M, Milgrom E (1990) Molecular action of progesterone. Int J BioChemiPhysics 22:579\u2013594","journal-title":"Int J BioChemiPhysics"},{"key":"379_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/bcr450","volume":"4","author":"JD Graham","year":"2002","unstructured":"Graham JD, Clarke CL (2002) Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells. Breast Cancer Res 4:187\u2013190","journal-title":"Breast Cancer Res"},{"key":"379_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fendo.2012.00007","volume":"3","author":"SK Mani","year":"2012","unstructured":"Mani SK, Oyola MG (2012) Progesterone signaling mechanisms in brain and behavior. Front Endocrinol (Lausanne) 3:7. \nhttps:\/\/doi.org\/10.3389\/fendo.2012.00007","journal-title":"Front Endocrinol (Lausanne)"},{"key":"379_CR14","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1200\/JCO.1988.6.7.1076","volume":"6","author":"B Fisher","year":"1988","unstructured":"Fisher B, Redmond C, Fisher ER, Caplan R (1988) Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol 6:1076\u20131087","journal-title":"J Clin Oncol"},{"key":"379_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1023\/A:1014820500738","volume":"72","author":"PA Mote","year":"2002","unstructured":"Mote PA, Bartow S, Tran N, Clarke CL (2002) Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat 72:163\u2013172","journal-title":"Breast Cancer Res Treat"},{"key":"379_CR16","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s10549-013-2592-0","volume":"139","author":"CA Gabriel","year":"2013","unstructured":"Gabriel CA, Mitra N, Demichele A, Rebbeck T (2013) Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women. Breast Cancer Res Treat 139:833\u2013843. \nhttps:\/\/doi.org\/10.1007\/s10549-013-2592-0","journal-title":"Breast Cancer Res Treat"},{"key":"379_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1158\/1055-9965.EPI-05-0679","volume":"15","author":"KA Pooley","year":"2006","unstructured":"Pooley KA, Healey CS, Smith PL, Pharoah PD, Thompson D, Tee L, West J, Jordan C et al (2006) Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach. Cancer Epidemiol Biomark Prev 15:675\u2013682","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"379_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/jnci\/dji007","volume":"97","author":"CL Pearce","year":"2005","unstructured":"Pearce CL, Hirschhorn JN, Wu AH, Burtt NP, Stram DO, Young S, Kolonel LN, Henderson BE et al (2005) Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis. J Natl Cancer Inst 97:51\u201359","journal-title":"J Natl Cancer Inst"},{"key":"379_CR19","doi-asserted-by":"publisher","first-page":"8891","DOI":"10.1158\/0008-5472.CAN-04-1256","volume":"64","author":"B Gold","year":"2004","unstructured":"Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H et al (2004) Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res 64:8891\u20138900","journal-title":"Cancer Res"},{"key":"379_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10549-007-9627-3","volume":"109","author":"SE Johnatty","year":"2008","unstructured":"Johnatty SE, Spurdle AB, Beesley J, Chen X, Hopper JL, Duffy DL, Chenevix-Trench G (2008) Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies. Breast Cancer Res Treat 109:91\u201399","journal-title":"Breast Cancer Res Treat"},{"key":"379_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/ijc.21847","volume":"119","author":"LP Fernandez","year":"2006","unstructured":"Fernandez LP, Milne RL, Barroso E, Cuadros M, Arias JI, Ruibal A, Benitez J, Ribas G (2006) Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: a Spanish case control study. Int J Cancer 119:467\u2013471","journal-title":"Int J Cancer"},{"key":"379_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1677\/jme.1.02170","volume":"38","author":"A Romano","year":"2007","unstructured":"Romano A, Delvoux B, Fischer DC, Groothuis P (2007) The PROGINS polymorphism of the human progesterone receptor diminishes the response to progesterone. J Mol Endocrinol 38:331\u2013350","journal-title":"J Mol Endocrinol"},{"key":"379_CR23","doi-asserted-by":"publisher","first-page":"e69367","DOI":"10.1371\/journal.pone.0069367","volume":"8","author":"T Clendenen","year":"2013","unstructured":"Clendenen T, Zeleniuch-Jacquotte A, Wirgin I, Koenig KL, Afanasyeva Y, Lundin E, Arslan AA, Axelsson T et al (2013) Genetic variants in hormone-related genes and risk of breast cancer. PLoS One 8:e69367. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0069367","journal-title":"PLoS One"},{"key":"379_CR24","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1158\/1055-9965.EPI-08-0168","volume":"17","author":"B Diergaarde","year":"2008","unstructured":"Diergaarde B, Potter JD, Jupe ER, Manjeshwar S, Shimasaki CD, Pugh TW, Defreese DC, Gramling BA et al (2008) Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomark Prev 17:1751\u20131759. \nhttps:\/\/doi.org\/10.1158\/1055-9965.EPI-08-0168","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"379_CR25","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/aje\/kwp298","volume":"170","author":"KW Reding","year":"2009","unstructured":"Reding KW, Li CI, Weiss NS, Chen C, Carlson CS, Duggan D, Thummel KE, Daling JR, Malone KE (2009) Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk. Am J Epidemiol 170:1241\u20131249. \nhttps:\/\/doi.org\/10.1093\/aje\/kwp298","journal-title":"Am J Epidemiol"},{"key":"379_CR26","first-page":"439","volume":"11","author":"AB Spurdle","year":"2002","unstructured":"Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Venter DJ, Southey MC, Chenevix-Trench G (2002) The progesterone receptor exon 4 Val660Leu G\/T polymorphism and risk of breast cancer in Australian women. Cancer Epidemiol Biomark Prev 11:439\u2013443","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"379_CR27","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1158\/1055-9965","volume":"18","author":"MM Gaudet","year":"2009","unstructured":"Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, Dunning AM, Morrison J et al (2009) Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomark Prev 18:1610\u20131616. \nhttps:\/\/doi.org\/10.1158\/1055-9965","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"379_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S1470-2045(11)70076-6","volume":"12","author":"B Zhang","year":"2011","unstructured":"Zhang B, Beeghly-Fadiel A, Long J, Zheng W (2011) Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol 12:477\u2013488. \nhttps:\/\/doi.org\/10.1016\/S1470-2045(11)70076-6","journal-title":"Lancet Oncol"},{"key":"379_CR29","doi-asserted-by":"publisher","first-page":"R636","DOI":"10.1186\/bcr928","volume":"6","author":"I Vivo De","year":"2004","unstructured":"De Vivo I, Hankinson SE, Colditz GA, Hunter DJ (2004) The progesterone receptor Val660-->Leu polymorphism and breast cancer risk. Breast Cancer Res 6:R636\u2013R639","journal-title":"Breast Cancer Res"},{"key":"379_CR30","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1158\/0008-5472.CAN-05-2715","volume":"66","author":"GS Huggins","year":"2006","unstructured":"Huggins GS, Wong JY, Hankinson SE, De Vivo I (2006) GATA5 activation of the progesterone receptor gene promoter in breast cancer cells is influenced by the +331G\/A polymorphism. Cancer Res 66:1384\u20131390","journal-title":"Cancer Res"},{"key":"379_CR31","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1158\/1055-9965.EPI-03-0301","volume":"13","author":"HS Feigelson","year":"2004","unstructured":"Feigelson HS, Rodriguez C, Jacobs EJ, Diver WR, Thun MJ, Calle EE (2004) No association between the progesterone receptor gene +331G\/A polymorphism and breast cancer. Cancer Epidemiol Biomark Prev 13:1084\u20131085","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"379_CR32","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s10549-010-0738-x","volume":"122","author":"KD Yu","year":"2010","unstructured":"Yu KD, Chen AX, Shao ZM (2010) No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis. Breast Cancer Res Treat 122:853\u2013858","journal-title":"Breast Cancer Res Treat"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-017-0379-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-017-0379-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-017-0379-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T18:17:08Z","timestamp":1585678628000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-017-0379-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,4]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["379"],"URL":"https:\/\/doi.org\/10.1007\/s12253-017-0379-z","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,4]]},"assertion":[{"value":"4 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}